{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T11:37:55Z","timestamp":1774525075856,"version":"3.50.1"},"reference-count":27,"publisher":"Walter de Gruyter GmbH","issue":"3","license":[{"start":{"date-parts":[[2017,8,19]],"date-time":"2017-08-19T00:00:00Z","timestamp":1503100800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,9,26]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Introduction. Chronic liver diseases (CLD) are an important cause of morbidity and mortality in general population. The aim of this study was to analyze potential differences between patients with CLD and healthy control group, and to estimate the severity of CLD by using simple questionnaires: general health questionnaire (GHQ-12) and chronic liver disease questionnaire (CLDQ). Methods. A cross-sectional pilot study was performed in Zemun Clinical Hospital during years 2014 and 2015. Sixty participants were divided into 4 groups (15 per group): chronic alcoholic hepatitis, other chronic hepatitis, liver cirrhosis, and healthy control group. Entire study population chose one of four offered answers of structured questionnaires GHQ-12 and CLDQ, based on which mean model of end-stage liver disease (MELD) and Child-Turcotte-Pugh (CTP) scores were calculated. Results. Mean GHQ12 and CLDQ scores were 10.5 and 5.21 \u00b1 1.11 respectively. Regarding certain CLDQ domain scores, a significant difference between alcoholic and non-alcoholic hepatitis groups in the worry domain was observed. Mean MELD score was 7.42 \u00b1 2.89 and did not differ between chronic hepatitis groups, while mean CTP score was 5.73 \u00b1 0.88. A statistically significant correlation was observed between GHQ12 and CLDQ scores (\u03c1 = -0.404, p &lt; 0.01), but not between subjective and objective scores. Conclusions. Mean GHQ12 and CLDQ scores pointed out to general psychological no-distress condition of the studied participants, as well as scarcely expressed CLD-specific complaints. Mean MELD and CTP scores indicated stable chronic liver diseases, with low three-month mortality rates in the cases of chronic hepatitis, as well as determination to Child A group in the case of liver cirrhosis.<\/jats:p>","DOI":"10.1515\/rjim-2017-0014","type":"journal-article","created":{"date-parts":[[2017,3,21]],"date-time":"2017-03-21T10:32:52Z","timestamp":1490092372000},"page":"129-137","source":"Crossref","is-referenced-by-count":2,"title":["A quality of life assessment and the correlation between generic and disease-specific questionnaires scores in outpatients with chronic liver disease-pilot study"],"prefix":"10.1515","volume":"55","author":[{"given":"Milica","family":"Obradovic","sequence":"first","affiliation":[{"name":"Zemun Clinical Hospital, School of Medicine, University of Belgrade, Belgrade , Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zoran","family":"Gluvic","sequence":"additional","affiliation":[{"name":"Zemun Clinical Hospital, School of Medicine, University of Belgrade, Belgrade , Serbia"},{"name":"School of Medicine, University of Belgrade, Belgrade , Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nina","family":"Petrovic","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Sciences Vinca, University of Belgrade, Laboratory of Radiobiology and Molecular Genetics, Mike Petrovica Alasa 12-14, 11001 Belgrade , Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Milan","family":"Obradovic","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Sciences Vinca, University of Belgrade, Laboratory of Radiobiology and Molecular Genetics, Mike Petrovica Alasa 12-14, 11001 Belgrade , Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ratko","family":"Tomasevic","sequence":"additional","affiliation":[{"name":"Zemun Clinical Hospital, School of Medicine, University of Belgrade, Belgrade , Serbia"},{"name":"School of Medicine, University of Belgrade, Belgrade , Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Predrag","family":"Dugalic","sequence":"additional","affiliation":[{"name":"Zemun Clinical Hospital, School of Medicine, University of Belgrade, Belgrade , Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Esma R.","family":"Isenovic","sequence":"additional","affiliation":[{"name":"Institute of Nuclear Sciences Vinca, University of Belgrade, Laboratory of Radiobiology and Molecular Genetics, Mike Petrovica Alasa 12-14, 11001 Belgrade , Serbia"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"374","published-online":{"date-parts":[[2017,8,19]]},"reference":[{"key":"2021040609520406115_j_rjim-2017-0014_ref_001_w2aab2b8c11b1b7b1ab1ab1Aa","doi-asserted-by":"crossref","unstructured":"1. SINGH V., LUTHRA S., ELAJAMI TK., WELTY FK. Resolution of NASH with weight loss documented by hepatic MRI. BMJ Case Reports; 2015.","DOI":"10.1136\/bcr-2014-207107"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_002_w2aab2b8c11b1b7b1ab1ab2Aa","doi-asserted-by":"crossref","unstructured":"2. The World Health Organization quality of life assessment (WHOQOL): Position paper from the World Health Organization, Social Science & Medicine 1995; 41(10), 1403-1409.","DOI":"10.1016\/0277-9536(95)00112-K"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_003_w2aab2b8c11b1b7b1ab1ab3Aa","doi-asserted-by":"crossref","unstructured":"3. GARRAT A., SCHMIDT L., MACKINTOSH A., FITZPATRICK R. Quality of life measurment: bibliographic study of paient assessed health outcome measures. BMJ Case Reports 2002; 1417.","DOI":"10.1136\/bmj.324.7351.1417"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_004_w2aab2b8c11b1b7b1ab1ab4Aa","doi-asserted-by":"crossref","unstructured":"4. GOLDBERG DP., HILLIER VF. A scaled version of the General Health Questionnaire. Psychological Medicine 1979; 9(1):139-45.","DOI":"10.1017\/S0033291700021644"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_005_w2aab2b8c11b1b7b1ab1ab5Aa","doi-asserted-by":"crossref","unstructured":"5. SPRANGERS MAG., AARONSON NK. The role of health care providers and significant others in evaluating the quality of life of patients with chronic disease: A review. Journal of Clinical Epidemiology 1992; 45(7):743-60.","DOI":"10.1016\/0895-4356(92)90052-O"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_006_w2aab2b8c11b1b7b1ab1ab6Aa","unstructured":"6. BAYLISS MS., GANDEK B., BUNGAY KM., DAVID S., HSU M-A., WARE JE. A Questionnaire to Assess the Generic and Disease-Specific Health Outcomes of Patients with Chronic Hepatitis C. Qual Life Res 1998; 7(1):39-55."},{"key":"2021040609520406115_j_rjim-2017-0014_ref_007_w2aab2b8c11b1b7b1ab1ab7Aa","doi-asserted-by":"crossref","unstructured":"7. YOUNOSSI Z., GUYATT G., KIWI M., BOPARAI N., KING D. Development of a disease specific questionnaire to measure health related quality of life in patients with chronic liver disease. Gut 1999; 45(2):295-300.","DOI":"10.1136\/gut.45.2.295"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_008_w2aab2b8c11b1b7b1ab1ab8Aa","doi-asserted-by":"crossref","unstructured":"8. POPOVIC DD., KOVACEVIC NV., KISIC TEPAVCEVIC DB., TRAJKOVIC GZ., ALEMPIJEVIC TM., et al. Validation of the chronic liver disease questionnaire in Serbian patients. World J Gastroentero 2013; 19(30):4950-7.","DOI":"10.3748\/wjg.v19.i30.4950"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_009_w2aab2b8c11b1b7b1ab1ab9Aa","unstructured":"9. MCCORMIC PM. Hepatic Cirrhosis, Sherlock\u2019s Diseases of the liver and billiary system. In: DOOLEY SJ., LOK A., BURROUGHS KA., HEATHCOTE J., editors. Sherlock's Diseases of the Liver and Biliary System, 12th Edition; Wiley- Blackwell; 2011:103-20."},{"key":"2021040609520406115_j_rjim-2017-0014_ref_010_w2aab2b8c11b1b7b1ab1ac10Aa","doi-asserted-by":"crossref","unstructured":"10. SARAVANAN P., CHAU WF., ROBERTS N., VEDHARA K., GREENWOOD R., DAYAN CM. Psychological well-being in patients on \u201cadequate\u201d doses of L-thyroxine: results of a large, controlled community-based questionnaire study. Clin Endocrin 2002; 57:577-85.","DOI":"10.1046\/j.1365-2265.2002.01654.x"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_011_w2aab2b8c11b1b7b1ab1ac11Aa","doi-asserted-by":"crossref","unstructured":"11. KAMATH PS., KIM WR. The model for end-stage liver disease (MELD). Hepatology 2007, 45(3):797-805.","DOI":"10.1002\/hep.21563"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_012_w2aab2b8c11b1b7b1ab1ac12Aa","doi-asserted-by":"crossref","unstructured":"12. CHOLONGITAS E., PAPATHEODORIDIS GV., VANGELI M., TERRENI N., PATCH D., BURROUGHS AK. Systematic review: the model for end-stage liver disease - should it replace Child-Pugh's classification for assessing prognosis in cirrhosis? Alimentary Pharmacology & Therapeutics 2005; 22(11-12):1079-89.","DOI":"10.1111\/j.1365-2036.2005.02691.x"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_013_w2aab2b8c11b1b7b1ab1ac13Aa","doi-asserted-by":"crossref","unstructured":"13. H\u00c4USER W., HOLTMANN G., GRANDT D. Determinants of health-related quality of life in patients with chronic liver diseases. Clin Gastroenter Hepatol. 2004; 2(2):157-63.","DOI":"10.1016\/S1542-3565(03)00315-X"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_014_w2aab2b8c11b1b7b1ab1ac14Aa","doi-asserted-by":"crossref","unstructured":"14. GUTTELING JJ., DE MAN RA., VAN DER PLAS SM., SCHALM SW., BUSSCHBACH JJW, DARLINGTON ASE. Determinants of quality of life in chronic liver patients. Aliment Pharmacol Therap 2006; 23(11):1629-35.","DOI":"10.1111\/j.1365-2036.2006.02934.x"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_015_w2aab2b8c11b1b7b1ab1ac15Aa","doi-asserted-by":"crossref","unstructured":"15. AFENDY A., KALLMAN JB., STEPANOVA M., YOUNOSZAI Z., AQUINO RD., BIANCHI G., et al. Predictors of healthrelated quality of life in patients with chronic liver disease. Aliment Pharmacol Therap 2009; 30(5):469-76.","DOI":"10.1111\/j.1365-2036.2009.04061.x"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_016_w2aab2b8c11b1b7b1ab1ac16Aa","doi-asserted-by":"crossref","unstructured":"16. PARKASH O., IQBAL R., JAFRI F., AZAM I., JAFRI W. Frequency of poor quality of life and predictors of health related quality of life in cirrhosis at a tertiary care hospital Pakistan. BMC Research Notes 2012; 5: 446.","DOI":"10.1186\/1756-0500-5-446"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_017_w2aab2b8c11b1b7b1ab1ac17Aa","doi-asserted-by":"crossref","unstructured":"17. CHE YH., YOU J., CHOUNGSUVIVATWONG V., LI L., SRICPLUNG H., YAN YZ., et al. Dynamics and Liver Disease Specific Aspects of Quality of Life Among Patients with Chronic Liver Disease in Yunnan, China. Asian Pac J Cancer Prev 2014; 15(12): 4765-71.","DOI":"10.7314\/APJCP.2014.15.12.4765"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_018_w2aab2b8c11b1b7b1ab1ac18Aa","doi-asserted-by":"crossref","unstructured":"18. CHANG S-C., YANG S-S., CHANG C-C., LIN C-C., CHUNG Y-C., LI T-C. Assessment of health-related quality of life in antiviral-treated Taiwanese chronic hepatitis C patients using SF-36 and CLDQ. Health Qual Life Outcomes 2014; 12:97.","DOI":"10.1186\/1477-7525-12-97"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_019_w2aab2b8c11b1b7b1ab1ac19Aa","doi-asserted-by":"crossref","unstructured":"19. THIELE M., ASKGAARD G., TIMM HB., HAMBERG O., GLUUD LL. Predictors of Health-Related Quality of Life in Outpatients with Cirrhosis: Results from a Prospective Cohort. Hepatitis Res Treat 2013; 2013.","DOI":"10.1155\/2013\/479639"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_020_w2aab2b8c11b1b7b1ab1ac20Aa","doi-asserted-by":"crossref","unstructured":"20. BONDINI S., KALLMAN J., DAN A., YOUNOSZAI Z., RAMSEY L., NADER F., et al. Health-related quality of life in patients with chronic hepatitis B. Liver Int 2007; 27(8):1119-25.","DOI":"10.1111\/j.1478-3231.2007.01558.x"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_021_w2aab2b8c11b1b7b1ab1ac21Aa","doi-asserted-by":"crossref","unstructured":"21. YOUNOSSI ZM., BOPARAI N., PRICE LL., KIWI ML., MCCORMICK M., GUYATT G.Health-related quality of life in chronic liver disease: the impact of type and severity of disease. Am J Gastroenterol 2001; 96(7):2199-205.","DOI":"10.1111\/j.1572-0241.2001.03956.x"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_022_w2aab2b8c11b1b7b1ab1ac22Aa","unstructured":"22. SVIRTLIH N., PAVIC S., TERZIC D., DELI\u0106 D., SIMONOVIC J., GVOZDENOVIC E. Reduced quality of life in patients with chronic viral liver disease as assessed by SF12 questionnaire. J Gastrointestin Liver Dis 2008; 17(4):405-9."},{"key":"2021040609520406115_j_rjim-2017-0014_ref_023_w2aab2b8c11b1b7b1ab1ac23Aa","doi-asserted-by":"crossref","unstructured":"23. DAN AA., KALLMAN JB., WHEELER A., YOUNOSZAI Z., COLLANTES R., BONDINI S., et al. Health-related quality of life in patients with non-alcoholic fatty liver disease. Alimen Pharmacol Therap 2007; 26(6):815-20.","DOI":"10.1111\/j.1365-2036.2007.03426.x"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_024_w2aab2b8c11b1b7b1ab1ac24Aa","doi-asserted-by":"crossref","unstructured":"24. PAVIC S., DELIC D., SIMONOVIC J., SVIRTLIH N. Quality of life in patients with chronic hepatitis C. Srp Arh Celok Lek 2011; 139(3-4):165-9.","DOI":"10.2298\/SARH1104165P"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_025_w2aab2b8c11b1b7b1ab1ac25Aa","doi-asserted-by":"crossref","unstructured":"25. MARTIN LM., DAN AA., YOUNOSSI Z. Measurement of health-related quality of life in patients with chronic liver disease. Liver Transplantation 2006; 12(1):22-3.","DOI":"10.1002\/lt.20575"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_026_w2aab2b8c11b1b7b1ab1ac26Aa","doi-asserted-by":"crossref","unstructured":"26. KALAITZAKIS E., JOSEFSSON A., BJ\u00d6RNSSON E. Type and etiology of liver cirrhosis are not related to the presence of hepatic encephalopathy or health-related quality of life: a cross-sectional study. BMC Gastroenterol 2008; 8(1):46.","DOI":"10.1186\/1471-230X-8-46"},{"key":"2021040609520406115_j_rjim-2017-0014_ref_027_w2aab2b8c11b1b7b1ab1ac27Aa","doi-asserted-by":"crossref","unstructured":"27. GOTARDO DRM., STRAUSS E., TEIXEIRA M-CD., MACHADO MCC.Liver transplantation and quality of life: relevance of a specific liver disease questionnaire. Liver Int 2008; 28(1):99-106.","DOI":"10.1111\/j.1478-3231.2007.01606.x"}],"container-title":["Romanian Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/content.sciendo.com\/view\/journals\/rjim\/55\/3\/article-p129.xml","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.sciendo.com\/article\/10.1515\/rjim-2017-0014","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,23]],"date-time":"2024-06-23T04:33:08Z","timestamp":1719117188000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.sciendo.com\/article\/10.1515\/rjim-2017-0014"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8,19]]},"references-count":27,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2017,8,19]]},"published-print":{"date-parts":[[2017,9,26]]}},"alternative-id":["10.1515\/rjim-2017-0014"],"URL":"https:\/\/doi.org\/10.1515\/rjim-2017-0014","relation":{},"ISSN":["2501-062X"],"issn-type":[{"value":"2501-062X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,8,19]]}}}